Sunday, December 25, 2022
Washington: The U.S. Food and Drug Administration (USFDA) announced that it will overhaul packaging labels for the emergency contraceptive pill, Plan B, that women can take after having sex to prevent a pregnancy.
The federal agency said it will remove references on the contraception's packaging that claim, without scientific evidence, that the pill prevents a fertilized egg from implanting in the womb.
The new labels are intended to further distinguish emergency contraception - also known as the morning after pill - from abortion pills, which end a pregnancy after a fertilized egg has implanted in the lining of a woman's uterus.
In a memo released, the USFDA clarified that taking Plan B pills is not the same as an abortion, a fact that has long been understood in the medical community.
"Evidence does not support that the drug affects implantation or maintenance of a pregnancy after implantation, therefore it does not terminate a pregnancy," the USFDA said in its statement.
The agency added that the emergency contraception works similarly to birth control in preventing pregnancy, but contains a higher dose of levonorgestrel. The pill prevents ovulation.
About a quarter of women say they've used emergency contraception pills at some point, according to a survey by the Centers for Disease Control released last year.
Still, concern has swirled that access to emergency contraception such as Plan B might be limited in some states, after the U.S. Supreme Court overturned the constitutional right to an abortion this summer.
Nevada's Republican governor-elect said he'd consider banning the pill during a debate this year. School clinics in Idaho also prohibited the pills under a law banning public funding for "abortion related services" last year.
The USFDA has approved Plan B for use up to 72 hours, or three days, after unprotected sex. Women are able to get emergency contraception over the counter.
Confession in criminal proceedings: Ground for conviction ?
USFDA gives approval for Lymphoma Therapy
PCI directs State Pharmacy Councils to expedite transfer of registration of Pharmacist
300 life-saving drugs needed from Indian Pharma Cos: Saudi Arab
Registration for sale of Medical Devices: Procedure and conditions
NPPA fixes Retail Price of 10 formulations: December 2022
Drug recall: This Blood Pressure tablets recalled
Kerala to cancel licences of Medical Stores selling antibiotics without prescription
Bulk transfer of Blood and Blood Components: Procedure and Conditions
Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/12/25/usfda-changes-plan-b-label-of-contraceptive-pills/
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment